A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control.
source https://www.sciencedaily.com/releases/2026/04/260411022035.htm
Trump admin’s coal investments assist plants with repeated violations
-
In 2023, after years of pollution, equipment failures, and health concerns,
the Cumberland Fossil Plant in Tennessee was slated to close within the
decad...
10 hours ago
No comments:
Post a Comment